Introduction
============

The survey of reported liquid chromatography tandem mass spectrometry (HPLC-MS/MS) methods from literatures for the determination of amphetamine and human metabolites in waters (van Nuijs et al. 2009\[[@R28]\]; Zuccato et al., 2005\[[@R35]\], 2008\[[@R34]\]; Castiglioni et al., 2006\[[@R6]\]; Hearn et al., 1991\[[@R15]\]; Bones et al., 2007\[[@R5]\]) is discussed in this paper. The higher performance liquid chromatography-mass spectrometry (HPLC-MS) or with tandem mass spectrometry (HPLC-MS/MS) were becoming popular in their separation and detection capabilities, as they appear very rapid, sensitive and selective method at ng/mL concentration levels. The concentrations of amphetamine and its metabolites in aqueous media using HPLC-MS or HPLC-MS/MS appeared to have largely replaced GC-MS in the analysis of illicit substances particularly in aqueous media. The extraction volumes, mobile phases, detectors (interfaces) and acquisition modes used by different scientists to provide sensitivity and selectivity are shown. The separation procedures rely on the principles of reversed-phase columns with different solvent gradients depending on applications. Tabulated are limits of quantifications depending on matrices for quantification and confirmation of drugs. Recently, variations over convectional HPLC-MS method have appeared in the literature with the name: Ultra-performance liquid chromatography (UPLC-MS/MS) is unique for its short columns packed with small particles sizes and stability at pH range (Bijlsma et al., 2009\[[@R3]\]; Wood et al., 2005\[[@R30]\]; Huerta-Fontela et al., 2008\[[@R17]\]; Boleda et al., 2007\[[@R4]\]; Kasprzyk-Hordern et al., 2007\[[@R21]\], 2008\[[@R20]\]). With the development of this relatively new technology, a shorter analysis times as well as gain in separation, efficiency, resolution and sensitivity have been reported. To minimize the effects of ion suppression on the analytical signal, a relatively new HILIC (Hydrophilic interaction chromatography) technique was also carried out in some experiments. Since analytes were better retained on HILIC column, unaffected by ion suppression and a reduction in analytical signal was minimised, the possibilities of using HILIC approach in the quantitative determination of polar compounds such as amphetamine and its metabolites was apparently justified (van Nuijs et al., 2009\[[@R27]\]; Gheorghe et al., 2008\[[@R14]\]). The use of MS/MS with triple quadrupole (QqQ) analyzers with electrospray ionization (ESI^+^) were mostly used in selected reaction monitoring mode (SRM) to minimize the matrix interferences. The choices of ionization in ESI positive-ion mode were to have achieved ionizations and simultaneous determinations of analytes.

To assess inherent selectivity and peculiar reservations of each method based on the compound and its metabolites wide range of polarities and extraction challenges from different aquatic (wastewater, sediment, sludge) matrices, this paper therefore hopes to review the high quality work published in the literature on amphetamine and its metabolites using HPLC methods to maximise future application needs.

Amphetamine and Metabolites
===========================

Among the drugs classified as amphetamines are amphetamines (AM), methamphetamines (MA, "speed") and methylenedioxymethamphetamine (MDMA, "ecstasy or Adam"). They are usually taken orally but can be snorted, smoked or injected. They are addictive stimulant drugs that affect the central nervous system among other risks of dependence and abuse. Other designer drugs are methylenedioxyamphetamine (MDE, "eve") and 3,4-methylenedioxyamphetamine (MDA, "love pills") (EMCDDA, 2007\[[@R12]\]).

The major metabolic pathway involves deamination of cytochrome P450 to para- hydroxyl amphetamine and phenylacetone, this later compound is oxidised to benzoic acid and excreted as glucuronide or glycine (hippuric acid) conjugates. Smaller amounts of amphetamine are also converted to norepheridine by oxidation. Although most enzymes involved in amphetamine metabolism have not been clearly defined, CYP2D6 is known to be involved with the formation of 4-hydroxylamphetamine.

Since CYP2D6 is genetically polymorphic, population variation in amphetamine metabolism are a possibility (Ensslin et al., 1996\[[@R13]\]). Figure 1[(Fig. 1)](#F1){ref-type="fig"} shows that MDMA generates free and conjugated MDA, which is a common metabolite of MDE and MDMA. Other metabolites from MDMA are 4-hydroxy-3-methoxymethamphetamine, HMMA and 4-hydroxy-3-methoxyamphetamine, HMA (Kloss et al., 1984\[[@R22]\]). With normal urine pHs, approximately half of an administered dose of amphetamine is excreted as derivatives of alpha-hydroxylamphetamine and another approximately 30-40 % of the dose can be excreted as parent amphetamine, this is because the urinary recovery of amphetamine is depending on pH and urine flow rate (Dollery, 1991\[[@R9]\]).

HPLC-MS/MS Methodologies
========================

Emerging contaminants of various biological active compounds, pharmaceuticals, personal care products, herbicides and antibiotics are present in complex and varying compositions in wastewaters and sewages. The procedures employed by different authors and published in the literatures in the past decade which include sample pre-concentration as an important step to the determination of amphetamine and related metabolites, followed by higher performance liquid chromatographic-tandem mass spectrometry separation and detection have been reviewed and summarised in Table 1[(Tab. 1)](#T1){ref-type="fig"} (at the end of this paper) (References in Table 1: Bones et al., 2007\[[@R5]\]; Castiglioni et al., 2006\[[@R6]\]; Hearn et al., 1991\[[@R15]\]; Huerta-Fontela et al., 2008\[[@R17]\]; Kasprzyk-Hordern et al. 2007\[[@R21]\]).

Sample pre-concentration
------------------------

Improved sample clean-ups, pre-treatment, chromatographic separation, centrifugation, filtration, alternative ionization and the use of deuterated compounds as surrogate standards have been employed by authors (Kloss et al., 1984\[[@R22]\]; van Viet et al., 1990\[[@R29]\]; Ellenhorn and Barceloux 1988\[[@R11]\]; Kolbrich et al., 2006\[[@R23]\]; Cone, 1995\[[@R8]\]; Hilton and Thomas, 2003\[[@R16]\]; Marais and Laurens, 2009\[[@R24]\]) to reduce the signal effects thereby correcting the matrix influences. To avoid sample degradation, dark-glass bottles with samples stored at -20 ^o^C at a pH of 6 have been recommended (Hearn et al., 1991\[[@R15]\]; Bones et al., 2007\[[@R5]\]; Bijlsma et al., 2009\[[@R3]\]; Wood et al., 2005\[[@R30]\]). Solid phase extraction using different extraction protocols achieving different extraction method recoveries of 50-105 %, (Kloss et al., 1984\[[@R22]\]); 50-65 % (Ellenhorn and Barceloux, 1988\[[@R11]\]); 73-96 % (Hummel et al., 2006\[[@R18]\]); 90 % (Hilton and Thomas, 2003\[[@R16]\]), and 65-106 % (Drummer et al., 2007\[[@R10]\]) respectively. When using HPLC-MS/MS with electro spray ionization detector (ESI) as interface, the matrix effect is one of the major factors affecting the isolation and analysis of drugs in complex matrices like wastewaters and sewages (Hummel et al., 2006\[[@R18]\]). Co-elution of matrix substituents causes suppression or enhancement of signal which ultimately affects the accuracy and reliability of results.

Amphetamine in the aqueous environment
--------------------------------------

The major metabolites that have been so found and quantified are summarised in Table 2[(Tab. 2)](#T2){ref-type="fig"} (References in Table 2: Human metabolites identified in biological fluids: Chen et al., 2008\[[@R7]\]; Zhang and Zhou, 2007\[[@R33]\]; Quintana et al., 2005\[[@R26]\]; Wylie et al., 2005\[[@R31]\]; Yu et al., 2009\[[@R32]\]; Human metabolites identified in the aquatic environment: Kloss et al., 1984\[[@R22]\]; Ellenhorn and Barceloux, 1988\[[@R11]\]; Cone, 1995\[[@R8]\]; Ambre, 1985\[[@R1]\]). However, the presence of some human amphetamine metabolites identified in biological fluids (Kloss et al., 1984\[[@R22]\]; Cone, 1995\[[@R8]\]; Ambre, 1985\[[@R1]\]; Chen et al., 2008\[[@R7]\]; Zhang and Zhou, 2007\[[@R33]\]; Quintana et al. 2005\[[@R26]\]; Wylie et al., 2005\[[@R31]\]; Yu et al., 2009\[[@R32]\]) are yet to reported in the aquatic environment.

In many parts of Europe, amphetamine and its metabolites have been reported in many wastewaters, surface waters and sewage at nanogram and microgram concentration levels with influent samples containing more of amphetamine and metabolites than effluents collected from sewage treatment plants, STPs (Table 3[(Tab. 3)](#T3){ref-type="fig"}) (References in Table 3: Amphetamines: Zuccato et al., 2008\[[@R34]\]; Bijlsma et al., 2009\[[@R3]\]; Castiglioni et al., 2006\[[@R6]\]; Huerta-Fontela et al., 2008\[[@R17]\]; Postigo et al., 2008\[[@R25]\]; Huerta-Fontela et al., 2008\[[@R17]\]; Metamphetamine: Bartelt-Hunt et al., 2009\[[@R2]\]; Bijlsma et al., 2009\[[@R3]\]; Castiglioni et al., 2006\[[@R6]\]; Huerta-Fontela et al., 2008\[[@R17]\]; Jones-Lepp et al., 2004\[[@R19]\]; Postigo et al., 2008\[[@R25]\]; Hearn et al., 1991\[[@R15]\]; MDA: Huerta-Fontela et al., 2008\[[@R17]\]; Zuccato et al., 2005\[[@R35]\]; Bijlsma et al., 2009\[[@R3]\]; Castiglioni et al. 2006\[[@R6]\]; Huerta-Fontela et al., 2008\[[@R17]\]; MDMA: Zuccato et al., 2008\[[@R34]\]; Bijlsma et al., 2009\[[@R3]\]; Castiglioni et al., 2006\[[@R6]\]; Huerta-Fontela et al., 2008\[[@R17]\]; Huerta-Fontela et al., 2008\[[@R17]\]; Postigo et al., 2008\[[@R25]\]; Hearn et al., 1991\[[@R15]\]; Huerta-Fontela et al., 2008\[[@R17]\]; MDEA: Huerta-Fontela et al., 2008\[[@R17]\]; Castiglioni et al., 2006\[[@R6]\]; Bijlsma et al., 2009\[[@R3]\]; Huerta-Fontela et al., 2008\[[@R17]\]).

HPLC method performances
------------------------

The survey of reported HPLC-MS/MS methods for the determination of amphetamine and human metabolites in water with the extraction volumes, mobile phases, detectors (interfaces) and acquisition modes used by different scientists to provide sensitivity and selectivity is shown in Table 1[(Tab. 1)](#T1){ref-type="fig"}.

The application of LC-MS^2^ to the simultaneous analysis of a wide variety of illicit drugs in waste water was first reported by Castiglioni et al. (2006\[[@R6]\]). The HPLC column (XTerra MS C18, 100 x 2.1 mm, 3.5 µm) with four separate total gradient elution times of 28, 32, 36 and 26 min for amphetamines, cocainics, opiods and cannabinoids were reported respectively. Wastewater samples (50 mL) were spiked with 20 ng of internal standards (cocaine-*d*~3~, benzoylecgonine-*d*~3,~ norcocaine-*d*~3~, cocaethethylene-*d*~8~, amphetamine-*d*~6~, methamphetamine-*d*~9~, MDA-*d*~5~. MDMA-*d*~5~, MDEA-*d*~5~, morphine-*d*~3~, morphine-3β-D-glucuronide-*d*~3~, 6-acetylmorphine-*d*~6~, methadone-*d*~3~, EDDP-*d*~3~ and 11-nor9-carboxy-Δ-THC-*d*~3~) and extracted using a standard Oasis MCX SPE procedure. Quantitation was based on the MH^+^peak areas of the analyte relative to the MH^+^ peak areas of the corresponding internal standards. The mobile phase solvent A: acetic acid 0.05 % in water and solvent B: acetonitrile. But solvent A for cannabinoids was triethylamine 0.05 % in water. ESI gave abundant protonated molecule ions (MH^+^) for each of the analytes and internal standards. Measured quantitation ranges were: 0.2-1 µg/L for cocaine and its metabolites, 80-200 ng/L for morphine, 10 ng/L for 6-acetylmorphine, 60-90 ng/L for methadone and its metabolite 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine and lower than 20 ng/L for amphetamines. The overall method variability was ≤ 10 % for the influents, ≤ 5 % for effluents and recoveries in wastewater were ≥ 80 %.

The use of Polar Organic Chemical Integrative Samplers (POCIS) methodology for sampling was introduced by Bartelt-Hunt et al. (2009\[[@R2]\]), the samplers were installed in rivers upstream and downsteam of treated WWTP at five different sites. The HPLC separation was performed isocratically on a Betabasic-18 column (250 x 2.1 mm, 5 µm, and 50 ^o^C) with a mobile phase of methanol with 0.1 % formic acid in water. The electrospray ionization in positive mode (ESI^+^) by multiple reaction monitoring gave the mass spectrum of the analytes. Each of the POCIS devices was removed from its deployment canister, and the contents were transferred with 20 mL high-purity methanol into silane-treated vials, stored at -20 ^o^C and compounds were eluted with 50 mL of high-purity methanol through silane-treated gas gravity flow chromatography columns into 120 mL evaporation tubes. After addition of the internal standards (metamphetamine-*d*~9~, ^13^C~3~-caffeine, and ^13^C~8~-sulfamethazine), the eluates were evaporated to approximately 1 mL under nitrogen and quantitatively transferred to autosampler for analysis. The estimated detection limits for most compounds were less than 1 pg/µL while the averaged recovery was 123 ± 30 %; however, the determination of the uptake rates for the compounds of interest for quantitative analysis is the limitation of POCIS.

Ultra-performance liquid chromatography (UPLC-ESI-MS/MS) is a variation over convectional HPLC-MS method. The ultra-fast LC-MS^2^ is unique for its short columns packed with small particles sizes and stability at pH range; with the development of this relatively new technology, a shorter analysis times as well as gain in separation, efficiency, resolution and sensitivity are introduced (Huerta-Fontela et al., 2008\[[@R17]\]).

The occurrence of psychoactive drugs in wastewaters using the new UPLC-ESI- MS^2^ technique (Huerta-Fontela et al., 2008\[[@R17]\]; Wood et al., 2005\[[@R30]\]) on an Acquity BEH C~18~ UPLC column, (100mm x 2.imm i.d., 1.7 µm particle size) after enrichment by solid phase extraction (SPE). The optimized separation conditions were for solvent A: acetonitrile with 0.1 % formic acid; solvent B: 30 mM formic acid/ammonium formate (pH 3.5) at a flow rate of 0.5 mL/min. The ESI working in positive mode with acquisition in selected reaction mode (SRM) gave abundant protonated molecular ion of each compound as the precursor ion: nicotine (163\>130; 163\>117), cotinine (177\>80; 177\>98), caffeine (195\>138; 195\>110), paraxantine (181\>124; \>181\>96), amphetamine (136\>119; 136\>91), MDA (180\>163; 180\>105), metamphetamine (150\>91; 150\>119), MDMA (194\>163; 194\>105), MDEA (208\>163; 208\>133), ketamine (238\>125; 238\>220), cocaine (304\>182; 304\>105), benzoylecgonine (290\>169; 290\>150), LSD (324\>223; 324\>208), PCP (244\>85; 244\>159) and fentanyl (337\>188; 337\>105). The LODs were lower than 1.5 ng/L and 300 ng/L where LOQs were lower than 5 ng/L and 850 ng/L, respectively, with the recoveries ranged from 70 to 101 %.

At the University of Glamorgan, Sustainable Environmental Research Centre, UK, Kasprzyk-Hordern et al. (2007\[[@R21]\]) made use of the new, fast and sensitive method for the broad range of pharmaceuticals, illicit drugs which include amphetamines with triple quadrupole tandem mass spectrometry with positive-ion mode (ESI^+^) was used for separation of up to 30 compounds on Acquity UPLC BEH C~18~ column (1.7 µm; 1 mm x 100mm) with mobile phase A: (pH, 2.8) of 94.5 % of H~2~O, 5 % MeOH, 0.5 % CH~3~COOH and mobile phase B: (pH, 3.2) of 99.5 % MeOH and 0.5 % CH~3~COOH after Oasis MCX, sorbent extraction. The methods limits were of quantification ranged from 0.3 to 50 ng/L with the instrumental limit of quantification from 0.2 to 10 µg/L.

Bijlsma et al. (2009\[[@R3]\]) recently reported use of UPLC-MS/MS method came from for the simultaneous determination of amphetamines, cocaines, cannabis and their metabolites in surface and waste water. After SPE enrichment, the selected drugs were separated on Acquity BEH C~18~ UPLC column, (50 mm x 2.1 mm i.d., 1.7 µm particle size) with methanol (solvent A) and 5 mM ammonium acetate/0.1 % formic acid (solvent B). The use of MS/MS with triple quadrupole (QqQ) analyzers with electrospray ionization (ESI^+^) was used in selected reaction monitoring mode (SRM) to minimize the matrix interferences. The choice of ionization in ESI positive-ion mode was deliberate to have abundant ionization of THC-COOH as well as simultaneous determinations for all the analytes. The recoveries of 70-120 % were reported with precision of ≤ 20 % for all compounds.

Conclusions
===========

HPLC-MS has been widely used as a good technique for highly polar, highly molecular weight and thermolabile compounds for the determination of amphetamine and its active metabolites in waters. No hydrolysis, no derivatization, one-step extraction especially with the introduction of API and ESI interfaces, the technique has been popular.

The Oasis MCX was also a good choice because its mixed mode materials during loading, washing and elution steps allows improved selectivity towards basic analytes due to pH and polarity changes. The internal standard was found as valuable tool for standardization and quantification and has almost identical physicochemical properties like the normal drugs and their metabolites analogues. Like cocaine analysis and similar drugs, the Oasis HLB cartridge built of a hydrophilic and a lipophilic monomer and Oasis MCX cartridge - a mixed reversed-phase/cation-exchange - were common cartridges for drug extraction with good recoveries. However, insufficient reference standards in contrast to GC-MS technique (which has large data bases of mass spectral) has made HPLC less attractive in studies where structural confirmation is needed.
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